Growth factors and stem cells as treatments for stroke recovery

Physical Medicine and Rehabilitation Clinics of North America

Volumn 14, Issue 1 SUPPL., 2003, Pages

  Cairns, Kevin ^a   Finklestein, Seth P ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Viacord Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BASIC FIBROBLAST GROWTH FACTOR; FIBRINOLYTIC AGENT; GROWTH FACTOR; NEUROMODULIN; NEUROPROTECTIVE AGENT; NEUROTROPHIN; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD CLOT LYSIS; BONE MARROW CELL; BRAIN PERFUSION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFICACY; HAND MOVEMENT; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; MONKEY; MORBIDITY; MORTALITY; NEUROPROTECTION; NONHUMAN; OUTCOMES RESEARCH; PHYSICAL DISABILITY; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION; SIDE EFFECT; STEM CELL; STEM CELL TRANSPLANTATION; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

BONE MORPHOGENETIC PROTEINS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; FIBROBLAST GROWTH FACTOR 2; GAP-43 PROTEIN; HUMANS; NEUROPROTECTIVE AGENTS; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037327936     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-9651(02)00059-1     Document Type: Conference Paper

References (40)

1. Heart and stroke facts. Dallas (TX): American Heart Association; 1999.
2. Granger CV, Hamilton BB, Gresham GE, et al. The Stroke Rehabilitation Outcome Study: part II. Relative merits of the total Barthel Index score and four-item subscore in predicting patient outcome. Arch Phys Med Rehabil 1989;70:100-3.
3. Duncan P, Goldstein LB, Matchar D, et al. Measurement of motor recovery after stroke. Stroke 1992;23:1084-9.
4. Cramer SC, Finklestein SP. Reparative approaches: growth factors and other pharmacological treatments. In: Miller LP. editor. Stroke therapy: basic, preclinical, and clinical directions. New York: John Wiley & Sons; 1998.
5. Jorgenson HS, Nakayama H, Raaschou HO, et al. Outcome and time course of recovery in stroke. Part II: time course of recovery. The Copenhagan Stroke Study. Arch Phys Med Rehabil 1995;76:406-11.
6. Hier DB, Mondlock J, Caplan LR. Recovery of behavioral abnormalities after right hemisphere stroke. Neurology 1983;33:345-50.
7. Group. NR-PS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
8. Mattson MP, Culmsee C, Yu Z. Apoptic and antiapoptic mechanisms in stroke. Cell Tissue Res 2000;301:173-87.
9. Jones TA, Schallert T. Use-dependent growth of pyramidal neurons after neocortical damage. J Neurosci 1994;14:2140-52.
10. Kawamata T, Dietrich WD, Schallert T, et al. Intracisternal basic fibroblast growth factor (bFGF) enhances functional recovery and upregulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci U S A 1997;94:8179-84.
11. Cramer SC, Nelles G, Benson RR, et al. A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 1997;28:2518-27.
12. Gage FH. Mammalian neural stem cells. Science 2000;287:1433-8.
13. Fallon J, Reid S, Kinyamu R, et al. In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc Natl Acad Sci U S A 2000;97:14686-91.
14. Butefisch C, Hummelsheim H, Denzler P, et al. Repetitive training of isolated movements improves the outcome of motor rehabilitation of the centrally paretic hand. J Neurol Sci 1995;130:59-68.
15. Kunkel A, Kopp B, Muller G. Constraint-induced movement therapy for motor recovery in chronic stroke patients. Arch Phys Med Rehabil 1999;80:624-8.
16. Nugent JA, Schurr KA, Adams RD. A dose-response relationship between amount of weight bearing exercise and walking outcome following cerebrovascular accident. Arch Phys Med Rehabil 1994;75:399-402.
17. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982;217:855-7.
18. Johannson BB, Ohlsson A-L. Environment, social interaction, and physical activity as determinants of functional outcome after cerebral infarction in the rat. Exp Neurol 1996;139:322-7.
19. Kolb B, Gibb R. Environment enrichment and cortical injury: behavioral and anatomical consequences of frontal cortex lesions. Cereb Cortex 1991;1:189-98.
20. Rowntree S, Kolb B. Antibodies to bFGF block functional recovery and dendritic compensation after motor cortex lesions. Eur J Neurosci 1997;9:2432-42.
21. Nudo RJ, Wise BM, SiFuentes F, et al. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 1996;272:1791-4.
22. Nudo RJ, Miliken GW. Reorganization of movement representations in primary motor cortex following focal ischemics in adult squirrel monkeys. J Neurophysiol 1996;75:2144-9.
23. Taub E, Uswatte G, Pidikiti R. Constraint-induced movement therapy: a new family of techniques with broad application to physical rehabilitation - a clinical review. J Rehabil Res Dev 1999;36:237-51.
24. Speliotes EK, Caday CG, Do T, et al. Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Molecular Brain Research 1996;39:31-42.
25. Koketsu N, Berlove DJ, Moskowitz MA, et al. Pretreatment with intraventricular basic fibroblast growth factor (bFGF) decreases infarct size following focal cerebral ischemia in rats. Ann Neurol 1994;35:451-7.
26. Fisher M, Meadows ME, Do T, et al. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1995;15:953-9.
27. Jiang N, Finklestein SP, Do T. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J Neurol Sci 1996;139:173-9.
28. Sugimori H, Speller H, Finklestein SP. Intravenous basic fibroblast growth factor (bFGF, FGF-2) produces a persistent reduction in infarct volume following permanent focal ischemia in rats. Neurosci Lett 2001;300:13-6.
29. Ay I, Sugimori H, Finklestein SP. Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Molecular Brain Research 2001;87:71-80.
30. Kawamata T, Ren J, Cha JH, et al. Intracisternal antisense oligonucleotide to growth associated protein-43 (GAP-43) blocks the recovery-promoting effects of basic fibroblast growth factor (bFGF) after focal stroke. Exp Neurol 1999;158:89-96.
31. Palmer TD, Ray J, Gage FH. FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol Cell Neurosci 1995;6:474-86.
32. Clark WM, Schim JD, Kasner SE, et al. Trafermin in acute ischemic stroke: results of a phase II/III randomized efficacy study [abstract]. Neurology 2000;54:A88.
33. Bogousslavsky J, Victor SJ, Salinas EO, et al. Fiblast (Trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial [abstract]. Cerebrovasc Dis 2000;10(Suppl 2):1-16.
34. Jones WK, Richmond EA, White K, et al. Osteogenic protein-1 (OP-1) expression and processing in Chinese hamster ovary cells: isolation of a soluble complex containing the mature and pro-domains of OP-1. Growth Factors 1994;11:215-25.
35. Kawamata T, Ren J, Chan TC, et al. Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport 1998;9:1441-5.
36. Ren JM, Kaplan PL, Charette MF, et al. Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke. Neuropharmacology 2000;39:860-5.
37. Chen J, Li Y, Chopp M. Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 2000;39:711-6.
38. Kraus M, Massengel J, Stevens Z, et al. Cord blood cells restore central nervous system (CNS) function in a rat-stroke model system [abstract]. Journal of the American Society of Hematology 2000;96:495a.
39. Chen J, Sanberg PR, Yi Li, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001;32:2682-8.
40. Dijkhuizen RM, Ren J, Mandeville JB, et al. Functional magnetic resonance imaging of reoganization in rat brain after stroke. Proceedings of the National Academy of Sciences of the United States of America, October 23, 2001;98(22):12766-71.